A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Cancer Treat Rev. 1982 Dec;9 Suppl B:25-33. doi: 10.1016/s0305-7372(82)80032-7.
Cancer Treat Rev. 1982.
PMID: 6299551
Clinical Trial.
No abstract available.